C losed-chest catheter ablation of anomalous atrioventricular connections has been attempted using a variety of methods since initially reported in 1983.1 Initial use of direct current ablative energy resulted in variable success rates and high rates of procedural complications, particularly when used within the coronary sinus.2-6 The advent of steerable large surface area electrode catheters, allowing accurate and effective myocardial delivery of radiofrequency energy, has markedly enhanced the safety of closed-chest catheter ablation techniques. Several in-vestigators have recently reported large clinical series of accessory atrioventricular pathway ventricular insertion radiofrequency ablation.7-10 High rates of success using ventricular insertion ablation have rapidly transformed catheter ablation from an investigational procedure to the nonpharmacological therapy of choice for symptomatic Wolff-Parkinson-White syndrome.
Although short-term success is very well documented, long-term arrhythmogenic effect of the often multiple radiofrequency ventricular lesions created during accessory pathway ablation remains undefined. The potential of arrhythmogenesis led us to consider accessory atrioventricular pathway ablation from an atrial approach. Atrial insertion ablation procedures also avoid the inherent risks of prolonged arterial catheter manipulation and retrograde left ventricular catheterization required for ventricular insertion ablation procedures directed at left-sided accessory pathways. Finally, the atrial aspect of both tricuspid and mitral annuli is a relatively smooth, nonobstructed surface that simplifies catheter movement, thereby permitting rapid and accu-rate accessory pathway localization. The purpose of this study, therefore, was to evaluate the efficacy and safety of radiofrequency catheter ablation techniques developed to eliminate accessory atrioventricular pathway conduction by direction of ablative energy solely to endocardial atrial insertion sites.
Methods Patient Population
The study population comprised 114 patients (31 female and 83 male; mean age, 31.0±12.9 years), which represents the initial 1-year experience at each of the supporting hospitals. One hundred eleven patients experienced symptomatic orthodromic atrioventricular tachycardia, and 23 had spontaneous atrial fibrillation (21 of the 23 also experienced recurrent atrioventricular tachycardia). Thirty-three patients experienced one or more syncopal episodes, and four survived aborted sudden cardiac death due to rapidly conducting atrial fibrillation-induced ventricular fibrillation. Subjects had undergone 2.5+1.5 (range, zero to seven) unsuccessful medical therapy regimens before referral for ablation. Two patients in this series were asymptomatic at the time of presentation. They were referred for electrophysiological evaluation of Wolff-Parkinson-White syndrome due to their potentially hazardous active duty military career fields. They underwent ablation after documentation of sustained orthodromic atrioventricular reentrant tachycardia and theoretically lethal accessory pathway physiology at baseline electrophysiology study. Twelve Endocardial localization of accessory pathway atrial insertion was accomplished using a transseptal approach for all left-sided tracts, as illustrated in Figure 1 . A modified Brockenbrough method was used for transseptal catheterization in patients without a patent foramen ovale. Briefly, anteroposterior positioning of the transseptal catheter on the right atrial aspect of the interatrial septum was established fluoroscopically in a 300 right anterior oblique projection and guided by use of the coronary sinus catheter as a posterior puncture limit and a 6F straight pigtail catheter introduced to the aortic valve as the anterior puncture limit. Septal puncture was accomplished under continuous fluoroscopic observation using a 10- 
Follow-up Evaluation
All patients were continuously monitored on a telemetry ward for 2 days after the ablation procedure. Patients were not anticoagulated after the accessory pathway ablation procedure. Serial 12-lead ECG and creatine phosphokinase-MB fraction evaluation was performed every 6 hours for the initial 24 hours after ablation. Repeat echocardiographic, signal-averaged ECG, and maximal exercise stress evaluation was performed before discharge on the second postablation hospital day.
Routine outpatient follow-up using serial 12-lead ECGs was supplanted with repeated formal electrophysiological and angiographic evaluation 4-6 weeks after ablation when possible. Patients were then seen as outpatients every 3 months for the first year after ablation and yearly thereafter.
Statistical Analysis
Data are reported as mean+ 1 SD. The median value for number of radiofrequency applications per case is also reported due to an extremely asymmetric distribution of the data. Comparisons were analyzed for statistically significant differences using a two-tailed Stu Figure 2 . Forty-five-degree left anterior oblique ( Figure 3A ) and 300 right anterior oblique ( Figure 3B Figure 4 . A 300 right anterior oblique projection is shown in Figure 5A , and a 450 left anterior oblique view is shown in Figure 5B . Four of the 12 right free wall accessory pathways could not be adequately localized using a standard endocardial tricuspid ring map alone. Right coronary artery mapping successfully localized accessory pathway insertion site in three of the four patients, permitting successful ablation. In the fourth patient, a ventriculoatrial conduction time of 20 msec was recorded across a large extent of the tricuspid annulus without a discrete atrial insertion site location. Ablation in this patient was not successful. Figure 6 illustrates the sinus rhythm electrogram characteristics of a midseptal accessory pathway. Septal accessory pathways were localized and ablated using a femoral venous approach as demonstrated in the 300 right anterior oblique ( Figure 7A ) and 450 left anterior oblique views ( Figure 7B) (range, 1-24; median, 4) radiofrequency energy applications to eliminate accessory pathway conduction. As with other measures of ablation procedure efficiency, the number of radiofrequency applications required for successful ablation declined as knowledge and experience accumulated. The final 30 procedures in this series required only 3.3±3.0 energy applications for success (range, 1-12; median, 2). A "learning curve" phenomenon was also noted in total procedure and fluoroscopy times required for successful ablation. Overall time of ablation procedures for this patient series was 4 primary failures). The second ablation procedure was successful on 14 of 16 accessory pathways, but three recurred. These three patients elected to undergo a third ablation attempt, which again was only temporarily successful in all three.
Overall, six of 114 patients were not successfully treated with the atrial insertion ablation technique. Four of the six patient failures were among the first 30 cases attempted. Location of these accessory pathways was right free wall in four patients, left anterior in one patient, and left free wall in one patient. Three patients opted for surgical ablation (one after primary failure and two after third recurrence), and three patients remain on medical therapy (two after second failure and one after third recurrence). Two of the unsuccessful ablation patients had two accessory pathways at baseline. One of the two accessory pathways was successfully ablated in each of these patients. Atrial insertion ablation was successful in 11 of the 12 patients who had previously unsuccessful surgical or ventricular insertion ablation attempts at outside institutions. After two ablation attempts, conduction through a left fibrous trigone accessory pathway that was previously unsuccessfully addressed using an epicardial dissection technique could not be interrupted.
After atrial insertion ablation, no detectable myocardial enzyme release occurred in 99 patients. There were no detectable adverse hemodynamic or anatomic consequences of energy delivery in this patient series. No serial changes were found in preablation and postablation echocardiographic evaluation that included color flow Doppler assessment of valvular function. In addition to echocardiographic evaluation, 70 patients underwent preablation and postablation coronary angiography. No occurred before the initial 1-month follow-up visit and way ablation so proper transseptal catheter placement is routinely ensured. Presence of a probe patent foramen ovale is a common finding in this age group, occurring in <30% of patients, and lowers risk even further since needle puncture is not necessary for successful interatrial septal crossing. The long-term effects of transseptal catheterization have been well defined with essentially no adverse consequences even after balloon mitral valvuloplasty procedures using a much larger diameter transseptal sheath than that used for accessory atrioventricular pathway ablation.22 '23 In conclusion, the transvenous atrial insertion approach to accessory atrioventricular connection ablation is very safe and highly effective. Overall, atrial insertion ablation efficacy is equivalent to previously reported ventricular insertion ablation technique results. The transvenous atrial insertion ablation technique may have safety advantages when used for leftsided accessory atrioventricular connections since prolonged arterial cannulation, retrograde left ventricular catheterization, and catheter manipulation in the ascending aorta are not necessary. Prospective direct comparative studies of atrial and ventricular insertion ablation techniques will be required to establish firm guidelines for optimal accessory pathway ablation method.
